|
Name |
Tetramethylkaempferol
|
Molecular Formula | C19H18O6 | |
IUPAC Name* |
3,5,7-trimethoxy-2-(4-methoxyphenyl)chromen-4-one
|
|
SMILES |
COC1=CC=C(C=C1)C2=C(C(=O)C3=C(O2)C=C(C=C3OC)OC)OC
|
|
InChI |
InChI=1S/C19H18O6/c1-21-12-7-5-11(6-8-12)18-19(24-4)17(20)16-14(23-3)9-13(22-2)10-15(16)25-18/h5-10H,1-4H3
|
|
InChIKey |
YZWIIEJLESXODL-UHFFFAOYSA-N
|
|
Synonyms |
Tetramethylkaempferol; 16692-52-7; o-Tetramethylkaempferol; 3,4',5,7-tetramethoxyflavone; 3,5,7,4'-Tetramethoxyflavone; 3,5,7,4'-Tetra-O-methylkaempferol; 2-(4-Methoxyphenyl)-3,5,7-trimethoxy-4H-1-benzopyran-4-one; 3,5,7-trimethoxy-2-(4-methoxyphenyl)chromen-4-one; CHEMBL356036; 3,5,7-Trimethoxy-2-(4-methoxyphenyl)-4H-1-benzopyran-4-one; 4H-1-Benzopyran-4-one, 3,5,7-trimethoxy-2-(4-methoxyphenyl)-; 960ZC9V914; 2-(4-Methoxyphenyl)-3,5,7-trimethoxy-4-oxo-4H-1-benzopyran; UNII-960ZC9V914; Flavone, 3,4',5,7-tetramethoxy-; SCHEMBL1664159; 3,5,7-Trimethoxy-2-(4-methoxy-phenyl)-chromen-4-one; DTXSID801309500; BDBM50049398; LMPK12112699; AKOS032961907; DB-117064; FT-0777773; Q27271837; 3,5,7-Trimethoxy-2-(4-methoxyphenyl)-4H-chromen-4-one #
|
|
CAS | 16692-52-7 | |
PubChem CID | 631095 | |
ChEMBL ID | CHEMBL356036 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 342.3 | ALogp: | 3.3 |
HBD: | 0 | HBA: | 6 |
Rotatable Bonds: | 5 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 63.2 | Aromatic Rings: | 3 |
Heavy Atoms: | 25 | QED Weighted: | 0.691 |
Caco-2 Permeability: | -4.638 | MDCK Permeability: | 0.00004990 |
Pgp-inhibitor: | 1 | Pgp-substrate: | 0 |
Human Intestinal Absorption (HIA): | 0.005 | 20% Bioavailability (F20%): | 0.002 |
30% Bioavailability (F30%): | 0.014 |
Blood-Brain-Barrier Penetration (BBB): | 0.079 | Plasma Protein Binding (PPB): | 77.28% |
Volume Distribution (VD): | 0.948 | Fu: | 17.88% |
CYP1A2-inhibitor: | 0.864 | CYP1A2-substrate: | 0.971 |
CYP2C19-inhibitor: | 0.857 | CYP2C19-substrate: | 0.689 |
CYP2C9-inhibitor: | 0.849 | CYP2C9-substrate: | 0.939 |
CYP2D6-inhibitor: | 0.263 | CYP2D6-substrate: | 0.937 |
CYP3A4-inhibitor: | 0.801 | CYP3A4-substrate: | 0.459 |
Clearance (CL): | 5.487 | Half-life (T1/2): | 0.33 |
hERG Blockers: | 0.07 | Human Hepatotoxicity (H-HT): | 0.155 |
Drug-inuced Liver Injury (DILI): | 0.96 | AMES Toxicity: | 0.594 |
Rat Oral Acute Toxicity: | 0.083 | Maximum Recommended Daily Dose: | 0.076 |
Skin Sensitization: | 0.139 | Carcinogencity: | 0.051 |
Eye Corrosion: | 0.004 | Eye Irritation: | 0.357 |
Respiratory Toxicity: | 0.127 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC002205 | 0.688 | D06GCK | 0.448 | ||||
ENC001772 | 0.527 | D0A8FB | 0.370 | ||||
ENC005880 | 0.490 | D02LZB | 0.368 | ||||
ENC002952 | 0.490 | D0NJ3V | 0.356 | ||||
ENC001442 | 0.461 | D09DHY | 0.351 | ||||
ENC006013 | 0.455 | D01FFA | 0.333 | ||||
ENC005870 | 0.444 | D0VU8Q | 0.319 | ||||
ENC005871 | 0.444 | D0Y7TS | 0.318 | ||||
ENC005522 | 0.433 | D0G4KG | 0.309 | ||||
ENC002404 | 0.432 | D0K8KX | 0.300 |